Caplin Point Laboratories gets nod for slump sale of regulated markets injectable business

20 Nov 2018 Evaluate

Caplin Point Laboratories has received an approval for the slump sale of business undertaking of the Company (Regulated Markets Injectable Business, including USFDA approved Injectable plant) to its wholly owned subsidiary company which is in the process of being incorporated. The Board of Directors of the company at their meeting held on November 19, 2018, approved the same.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1832.50 45.15 (2.53%)
31-Dec-2025 11:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.00
Dr. Reddys Lab 1267.00
Cipla 1498.65
Zydus Lifesciences 909.90
Lupin 2095.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×